The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies

European Journal of Pharmacology

Volumn 817, Issue , 2017, Pages 86-95

  Perez Pardo, Paula ^a   Kliest, Tessa ^a   Dodiya, Hemraj B ^b   Broersen, Laus M ^a,c   Garssen, Johan ^a,c   Keshavarzian, Ali ^a,b   Kraneveld, Aletta D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c DANONE NUTRICIA RESEARCH   (Netherlands)

Author keywords

Alpha synuclein; Enteric nervous system; Food based therapies; Gastrointestinal dysfunction; Microbiota; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTICLE; BRAIN; DIET THERAPY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE; INTESTINE INNERVATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; ANIMAL; FOOD; GASTROINTESTINAL TRACT; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; ENTERIC NERVOUS SYSTEM; FOOD; GASTROINTESTINAL TRACT; HUMANS; PARKINSON DISEASE;

EID: 85019557445     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.05.042     Document Type: Article

References (152)

1. Aarsland, D., Creese, B., Politis, M., Chaudhuri, K.R., Ffytche, D.H., Weintraub, D., Ballard, C., Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 13 (2017), 217–231, 10.1038/nrneurol.2017.27.
2. Abbott, R.D., Petrovitch, H., White, L.R., Masaki, K.H., Tanner, C.M., Curb, J.D., Grandinetti, A., Blanchette, P.L., Popper, J.S., Ross, G.W., Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57 (2001), 456–462.
3. Abbott, R.D., Ross, G.W., Petrovitch, H., Tanner, C.M., Davis, D.G., Masaki, K.H., Launer, L.J., Curb, J.D., White, L.R., Bowel movement frequency in late-life and incidental Lewy bodies. Mov. Disord. Off. J. Mov. Disord. Soc. 22 (2007), 1581–1586, 10.1002/mds.21560.
4. Afshordel, S., Hagl, S., Werner, D., Röhner, N., Kögel, D., Bazan, N.G., Eckert, G.P., Omega-3 polyunsaturated fatty acids improve mitochondrial dysfunction in brain aging - Impact of Bcl-2 and NPD-1 like metabolites. Prostaglandins Leukot. Essent. Fat. Acids 92 (2014), 23–31, 10.1016/j.plefa.2014.05.008.
5. Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene, H., Ferrier, L., Houdeau, E., Fioramonti, J., Bueno, L., Theodorou, V., Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37 (2012), 1885–1895, 10.1016/j.psyneuen.2012.03.024.
6. Andrews, Z.B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J.D., Savitt, J.M., DiMarchi, R., Tschoep, M., Roth, R.H., Gao, X.-B., Horvath, T.L., Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J. Neurosci. Off. J. Soc. Neurosci. 29 (2009), 14057–14065, 10.1523/JNEUROSCI.3890-09.2009.
7. Angot, E., Steiner, J.A., Lema Tomé, C.M., Ekström, P., Mattsson, B., Björklund, A., Brundin, P., Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PloS One, 7, 2012, e39465, 10.1371/journal.pone.0039465.
8. Araki, W., Wurtman, R.J., How is membrane phospholipid biosynthesis controlled in neural tissues?. J. Neurosci. Res. 51 (1998), 667–674.
9. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.-M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., de Vos, W.M., Brunak, S., Doré, J., MetaHIT, Consortium, Antolín, M., Artiguenave, F., Blottiere, H.M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K.U., Friss, C., van de Guchte, M., Guedon, E., Haimet, F., Huber, W., van Hylckama-Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Mérieux, A., Melo Minardi, R., M'rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S.D., Bork, P., Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180, 10.1038/nature09944.
10. Banks, W.A., Dohgu, S., Lynch, J.L., Fleegal-DeMotta, M.A., Erickson, M.A., Nakaoke, R., Vo, T.Q., Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier. Endocrinology 149 (2008), 1514–1523, 10.1210/en.2007-1091.
11. Banks, W.A., Erickson, M.A., The blood–brain barrier and immune function and dysfunction. Spec. Issue Blood Brain Barrier 37 (2010), 26–32, 10.1016/j.nbd.2009.07.031.
12. Bazan, N.G., Molina, M.F., Gordon, W.C., NIH Public Access, 2012, 321–351, 10.1146/annurev.nutr.012809.104635.Docosahexaenoic.
13. Beach, T.G., Adler, C.H., Sue, L.I., Vedders, L., Lue, L., White Iii, C.L., Akiyama, H., Caviness, J.N., Shill, H.A., Sabbagh, M.N., Walker, D.G., Arizona Parkinson's Disease Consortium, Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. (Berl. ) 119 (2010), 689–702, 10.1007/s00401-010-0664-3.
14. Borre, Y.E., Moloney, R.D., Clarke, G., Dinan, T.G., Cryan, J.F., The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv. Exp. Med. Biol. 817 (2014), 373–403, 10.1007/978-1-4939-0897-4_17.
15. Bousquet, M., Saint-Pierre, M., Julien, C., Salem, N., Cicchetti, F., Calon, F., Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 22 (2008), 1213–1225, 10.1096/fj.07-9677com.
16. Braak, H., De Vos, R. a.I., Bohl, J., Del Tredici, K., Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 396 (2006), 67–72, 10.1016/j.neulet.2005.11.012.
17. Braak, H., Rüb, U., Gai, W.P., Del Tredici, K., Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110 (2003), 517–536, 10.1007/s00702-002-0808-2.
18. Braak, H., Sandmann-Keil, D., Gai, W., Braak, E., Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci. Lett. 265 (1999), 67–69.
19. Broersen, L.M., Kuipers, A.A.M., Balvers, M., van Wijk, N., Savelkoul, P.J.M., de Wilde, M.C., van der Beek, E.M., Sijben, J.W.C., Hageman, R.J.J., Kamphuis, P.J.G.H., Kiliaan, A.J., A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice. J. Alzheimers Dis. 33 (2013), 177–190, 10.3233/JAD-2012-112039.
20. Brown, C.T., Davis-Richardson, A.G., Giongo, A., Gano, K.A., Crabb, D.B., Mukherjee, N., Casella, G., Drew, J.C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C.H., Schatz, D., Atkinson, M.A., Triplett, E.W., Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PloS One, 6, 2011, e25792, 10.1371/journal.pone.0025792.
21. Brundin, P., Li, J.-Y., Holton, J.L., Lindvall, O., Revesz, T., Research in motion: the enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 9 (2008), 741–745, 10.1038/nrn2477.
22. Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M.R., Südhof, T.C., Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329 (2010), 1663–1667, 10.1126/science.1195227.
23. Cansev, M., Ulus, I.H., Wang, L., Maher, T.J., Wurtman, R.J., Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. Neurosci. Res. 62 (2008), 206–209, 10.1016/j.neures.2008.07.005.
24. Cassani, E., Privitera, G., Pezzoli, G., Pusani, C., Madio, C., Iorio, L., Barichella, M., Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol. Dietol. 57 (2011), 117–121.
25. Cersosimo, M.G., Raina, G.B., Pecci, C., Pellene, A., Calandra, C.R., Gutiérrez, C., Micheli, F.E., Benarroch, E.E., Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms. J. Neurol. 260 (2013), 1332–1338, 10.1007/s00415-012-6801-2.
26. Chaudhuri, K.R., Prieto-Jurcynska, C., Naidu, Y., Mitra, T., Frades-Payo, B., Tluk, S., Ruessmann, A., Odin, P., Macphee, G., Stocchi, F., Ondo, W., Sethi, K., Schapira, A.H.V., Martinez Castrillo, J.C., Martinez-Martin, P., The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov. Disord. Off. J. Mov. Disord. Soc. 25 (2010), 704–709, 10.1002/mds.22868.
27. Chaudhuri, K.R., Schapira, A.H., Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 8 (2009), 464–474, 10.1016/S1474-4422(09)70068-7.
28. Chen, H., Zhao, E.J., Zhang, W., Lu, Y., Liu, R., Huang, X., Ciesielski-Jones, A.J., Justice, M.A., Cousins, D.S., Peddada, S., Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis. Transl. Neurodegener., 4, 2015, 1, 10.1186/2047-9158-4-1.
29. Chen, W.C., Quigley, E.M.M., Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon!. Indian J. Med. Res. 140 (2014), 582–584.
30. Clairembault, T., Leclair-Visonneau, L., Neunlist, M., Derkinderen, P., Enteric glial cells: new players in Parkinson's disease?. Mov. Disord. Off. J. Mov. Disord. Soc. 30 (2015), 494–498, 10.1002/mds.25979.
31. Clemente, J.C., Ursell, L.K., Parfrey, L.W., Knight, R., The impact of the gut microbiota on human health: an integrative view. Cell 148 (2012), 1258–1270, 10.1016/j.cell.2012.01.035.
32. Corridoni, D., Pastorelli, L., Mattioli, B., Locovei, S., Ishikawa, D., Arseneau, K.O., Chieppa, M., Cominelli, F., Pizarro, T.T., Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PloS One, 7, 2012, e42067, 10.1371/journal.pone.0042067.
33. Crispo, J. a.G., Fortin, Y., Thibault, D.P., Emons, M., Bjerre, L.M., Kohen, D.E., Perez-Lloret, S., Mattison, D., Willis, A.W., Krewski, D., Trends in inpatient antiparkinson drug use in the USA, 2001–2012. Eur. J. Clin. Pharmacol., 2015, 10.1007/s00228-015-1881-4.
34. Cryan, J.F., Dinan, T.G., More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 40 (2015), 241–242, 10.1038/npp.2014.224.
35. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13 (2012), 701–712, 10.1038/nrn3346.
36. de Kivit, S., Kraneveld, A.D., Garssen, J., Willemsen, L.E.M., Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components. Eur. J. Pharmacol. 668:Suppl 1 (2011), S124–S132, 10.1016/j.ejphar.2011.05.086.
37. De Paula, J.A., Carmuega, E., Weill, R., Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol. Latinoam. 38 (2008), 16–25.
38. de Rijk, M.C., Launer, L.J., Berger, K., Breteler, M.M., Dartigues, J.F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., Hofman, A., Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research Group. Neurology 54 (2000), S21–S23.
39. Delattre, A.M., Kiss, A., Szawka, R.E., Anselmo-Franci, J.A., Bagatini, P.B., Xavier, L.L., Rigon, P., Achaval, M., Iagher, F., de David, C., Marroni, N.A.P., Ferraz, A.C., Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease. Neurosci. Res. 66 (2010), 256–264, 10.1016/j.neures.2009.11.006.
40. Delzenne, N.M., Oligosaccharides: state of the art. Proc. Nutr. Soc. 62 (2003), 177–182.
41. Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., Lee, S.-J., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA 106 (2009), 13010–13015, 10.1073/pnas.0903691106.
42. Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.M., Neunlist, M., Derkinderen, P., Colonic inflammation in Parkinson's disease. Neurobiol. Dis. 50 (2013), 42–48, 10.1016/j.nbd.2012.09.007.
43. Dikiy, I., Eliezer, D., Folding and misfolding of alpha-synuclein on membranes. Biochim. Biophys. Acta 1818 (2012), 1013–1018, 10.1016/j.bbamem.2011.09.008.
44. Doi, H., Sakakibara, R., Sato, M., Masaka, T., Kishi, M., Tateno, A., Tateno, F., Tsuyusaki, Y., Takahashi, O., Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease. J. Neurol. Sci. 319 (2012), 86–88, 10.1016/j.jns.2012.05.010.
45. dos Santos, E.F., Busanello, E.N.B., Miglioranza, A., Zanatta, A., Barchak, A.G., Vargas, C.R., Saute, J., Rosa, C., Carrion, M.J., Camargo, D., Dalbem, A., da Costa, J.C., de Sousa Miguel, S.R.P., de Mello Rieder, C.R., Wajner, M., Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease. Metab. Brain Dis. 24 (2009), 257–269, 10.1007/s11011-009-9139-4.
46. Epprecht, L., Schreglmann, S.R., Goetze, O., Woitalla, D., Baumann, C.R., Waldvogel, D., Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal. J. Neurol. 262 (2015), 1946–1953, 10.1007/s00415-015-7799-z.
47. Fasano, A., Visanji, N.P., Liu, L.W.C., Lang, A.E., Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 14 (2015), 625–639, 10.1016/S1474-4422(15)00007-1.
48. Forsyth, C.B., Shannon, K.M., Kordower, J.H., Voigt, R.M., Shaikh, M., Jaglin, J. a., Estes, J.D., Dodiya, H.B., Keshavarzian, A., Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One, 2011, 6, 10.1371/journal.pone.0028032.
49. Forsythe, P., Kunze, W.A., Voices from within: gut microbes and the CNS. Cell. Mol. Life Sci. CMLS 70 (2013), 55–69, 10.1007/s00018-012-1028-z.
50. Frei, R., Akdis, M., O'Mahony, L., Prebiotics, probiotics, synbiotics, and the immune system. Curr. Opin. Gastroenterol. 31 (2015), 153–158, 10.1097/MOG.0000000000000151.
51. Freitas, M.E., Ruiz-Lopez, M., Fox, S.H., Novel levodopa formulations for Parkinson's disease. CNS Drugs 30 (2016), 1079–1095, 10.1007/s40263-016-0386-8.
52. Galán, J.E., Collmer, A., Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284 (1999), 1322–1328.
53. Gallagher, D.A., Lees, A.J., Schrag, A., What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?. Mov. Disord. Off. J. Mov. Disord. Soc. 25 (2010), 2493–2500, 10.1002/mds.23394.
54. Ganapathy, V., Thangaraju, M., Prasad, P.D., Martin, P.M., Singh, N., Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 13 (2013), 869–874, 10.1016/j.coph.2013.08.006.
55. Gao, X., Chen, H., Schwarzschild, M.A., Ascherio, A., A prospective study of bowel movement frequency and risk of Parkinson's disease. Am. J. Epidemiol. 174 (2011), 546–551, 10.1093/aje/kwr119.
56. Gasbarrini, A., Lauritano, E.C., Gabrielli, M., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Small intestinal bacterial overgrowth: diagnosis and treatment. Dig. Dis. Basel Switz. 25 (2007), 237–240, 10.1159/000103892.
57. Gelpi, E., Navarro-Otano, J., Tolosa, E., Gaig, C., Compta, Y., Rey, M.J., Martí, M.J., Hernández, I., Valldeoriola, F., Reñé, R., Ribalta, T., Multiple organ involvement by alpha-synuclein pathology in lewy body disorders. Mov. Disord. 29 (2014), 1010–1018, 10.1002/mds.25776.
58. Gibb, W.R., Lees, A.J., The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol. Appl. Neurobiol. 15 (1989), 27–44.
59. Gibson, G.R., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125 (1995), 1401–1412, 10.1079/NRR200479.
60. Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C., Gage, F.H., Mechanisms underlying inflammation in neurodegeneration. Cell 140 (2010), 918–934, 10.1016/j.cell.2010.02.016.
61. Gold, A., Turkalp, Z.T., Munoz, D.G., Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 28 (2013), 237–240, 10.1002/mds.25298.
62. Grenham, S., Clarke, G., Cryan, J.F., Dinan, T.G., Brain-gut-microbe communication in health and disease. Front. Physiol., 2, 2011, 94, 10.3389/fphys.2011.00094.
63. Guan, J., Pavlovic, D., Dalkie, N., Waldvogel, H.J., O'Carroll, S.J., Green, C.R., Nicholson, L.F.B., Vascular degeneration in Parkinson's disease. Brain Pathol. Zur. Switz. 23 (2013), 154–164, 10.1111/j.1750-3639.2012.00628.x.
64. Haehner, A., Hummel, T., Reichmann, H., Olfactory dysfunction as a diagnostic marker for Parkinson's disease. Expert Rev. Neurother. 9 (2009), 1773–1779, 10.1586/ern.09.115.
65. Hardoff, R., Sula, M., Tamir, A., Soil, A., Front, A., Badarna, S., Honigman, S., Giladi, N., Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 16 (2001), 1041–1047.
66. Hawkes, C.H., Del Tredici, K., Braak, H., A timeline for Parkinson's disease. Park. Relat. Disord. 16 (2010), 79–84, 10.1016/j.parkreldis.2009.08.007.
67. Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson's disease: the dual hit theory revisited. Ann. N. Y. Acad. Sci. 1170 (2009), 615–622, 10.1111/j.1749-6632.2009.04365.x.
68. Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson's disease: the dual hit theory revisited. Ann. N. Y. Acad. Sci. 1170 (2009), 615–622, 10.1111/j.1749-6632.2009.04365.x.
69. Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson's disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33 (2007), 599–614, 10.1111/j.1365-2990.2007.00874.x.
70. Holguin, S., Huang, Y., Liu, J., Wurtman, R., Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav. Brain Res. 191 (2008), 11–16, 10.1016/j.bbr.2008.02.042.
71. Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., Li, J.-Y., Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. (Berl. ) 128 (2014), 805–820, 10.1007/s00401-014-1343-6.
72. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Chow, J., Reisman, S.E., Petrosino, J.F., Patterson, P.H., Mazmanian, S.K., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463, 10.1016/j.cell.2013.11.024.
73. Hueck, C.J., Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. MMBR 62 (1998), 379–433.
74. Janickova, H., Rudajev, V., Dolejsi, E., Koivisto, H., Jakubik, J., Tanila, H., El-Fakahany, E.E., Dolezal, V., Lipid-based diets Improve muscarinic neurotransmission in the hippocampus of transgenic APPswe/PS1dE9 mice. Curr. Alzheimer Res. 12 (2015), 923–931.
75. Jeurink, P.V., van Esch, B.C.A.M., Rijnierse, A., Garssen, J., Knippels, L.M.J., Mechanisms underlying immune effects of dietary oligosaccharides. Am. J. Clin. Nutr. 98 (2013), 572S–577SS, 10.3945/ajcn.112.038596.
76. Jost, W.H., Gastrointestinal dysfunction in Parkinson's Disease. J. Neurol. Sci. 289 (2010), 69–73, 10.1016/j.jns.2009.08.020.
77. Jucker, M., Walker, L.C., Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501 (2013), 45–51, 10.1038/nature12481.
78. Kamel, F., Goldman, S.M., Umbach, D.M., Chen, H., Richardson, G., Barber, M.R., Meng, C., Marras, C., Korell, M., Kasten, M., Hoppin, J.A., Comyns, K., Chade, A., Blair, A., Bhudhikanok, G.S., Webster Ross, G., William Langston, J., Sandler, D.P., Tanner, C.M., Dietary fat intake, pesticide use, and Parkinson's disease. Park. Relat. Disord. 20 (2014), 82–87, 10.1016/j.parkreldis.2013.09.023.
79. Kaye, J., Gage, H., Kimber, A., Storey, L., Trend, P., Excess burden of constipation in Parkinson's disease: a pilot study. Mov. Disord. 21 (2006), 1270–1273, 10.1002/mds.20942.
80. Keshavarzian, A., Green, S.J., Engen, P.A., Voigt, R.M., Naqib, A., Forsyth, C.B., Mutlu, E., Shannon, K.M., Colonic bacterial composition in Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 30 (2015), 1351–1360, 10.1002/mds.26307.
81. Khalighi, A.R., Khalighi, M.R., Behdani, R., Jamali, J., Khosravi, A., Kouhestani, S., Radmanesh, H., Esmaeelzadeh, S., Khalighi, N., Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)–a pilot study. Indian J. Med. Res. 140 (2014), 604–608.
82. Kieburtz, K., Wunderle, K.B., Parkinson's disease: evidence for environmental risk factors. Mov. Disord. Off. J. Mov. Disord. Soc. 28 (2013), 8–13, 10.1002/mds.25150.
83. Klingelhoefer, L., Reichmann, H., Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors. Nat. Rev. Neurol. 11 (2015), 625–636, 10.1038/nrneurol.2015.197.
84. Kordower, J.H., Brundin, P., Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another? Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol., 34, 2009, 254, 10.1038/npp.2008.161.
85. Kovács, Z., Benjamins, E., Grau, K., Ur Rehman, A., Ebrahimi, M., Czermak, P., Recent developments in manufacturing oligosaccharides with prebiotic functions. Adv. Biochem. Eng. Biotechnol. 143 (2014), 257–295, 10.1007/10_2013_237.
86. Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., Galmiche, J.-P., Damier, P., Derkinderen, P., Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PloS One, 5, 2010, e12728, 10.1371/journal.pone.0012728.
87. Lee, H.M., Koh, S.-B., Many faces of Parkinson's disease: non-motor symptoms of Parkinson's disease. J. Mov. Disord. 8 (2015), 92–97, 10.14802/jmd.15003.
88. Li, J.-Y., Englund, E., Holton, J.L., Soulet, D., Hagell, P., Lees, A.J., Lashley, T., Quinn, N.P., Rehncrona, S., Björklund, A., Widner, H., Revesz, T., Lindvall, O., Brundin, P., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14 (2008), 501–503, 10.1038/nm1746.
89. Liang, S., Wang, T., Hu, X., Luo, J., Li, W., Wu, X., Duan, Y., Jin, F., Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience, 2015, 10.1016/j.neuroscience.2015.09.033.
90. Lim, S.-Y., Lang, A.E., The nonmotor symptoms of Parkinson's disease–an overview. Mov. Disord. Off. J. Mov. Disord. Soc. 25:Suppl 1 (2010), S123–S130, 10.1002/mds.22786.
91. Luong, K.V.Q., Nguyễn, L.T.H., The beneficial role of thiamine in Parkinson disease. CNS Neurosci. Ther. 19 (2013), 461–468, 10.1111/cns.12078.
92. Maes, M., Kubera, M., Leunis, J.-C., The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 29 (2008), 117–124.
93. Marrinan, S., Emmanuel, A.V., Burn, D.J., Delayed gastric emptying in Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 00 (2013), 1–10, 10.1002/mds.25708.
94. Martinez-Martin, P., The importance of non-motor disturbances to quality of life in Parkinson's disease. J. Neurol. Sci. 310 (2011), 12–16, 10.1016/j.jns.2011.05.006.
95. Maslowski, K.M., Mackay, C.R., Diet, gut microbiota and immune responses. Nat. Immunol. 12 (2011), 5–9, 10.1038/ni0111-5.
96. Meksawan, K., Chaotrakul, C., Leeaphorn, N., Gonlchanvit, S., Eiam-Ong, S., Kanjanabuch, T., Effects of fructo-oligosaccharide supplementation on constipation in elderly continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int. J. Int. Soc. Perit. Dial., 2014, 10.3747/pdi.2014.00015.
97. Miller, R.L., James-Kracke, M., Sun, G.Y., Sun, A.Y., Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 34 (2009), 55–65, 10.1007/s11064-008-9656-2.
98. Mulak, A., Bonaz, B., Brain-gut-microbiota axis in Parkinson's disease. World J. Gastroenterol. WJG 21 (2015), 10609–10620, 10.3748/wjg.v21.i37.10609.
99. Myers, C.S., Fisher, H., Wagner, G.C., Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats. Pharmacol. Biochem. Behav. 52 (1995), 749–753.
100. Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., Kunugi, H., BDNF function and intracellular signaling in neurons. Histol. Histopathol. 25 (2010), 237–258.
101. Nussbaum, R.L., Ellis, C.E., Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348 (2003), 1356–1364, 10.1056/NEJM2003ra020003.
102. Ojetti, V., Ianiro, G., Tortora, A., D'Angelo, G., Di Rienzo, T.A., Bibbò, S., Migneco, A., Gasbarrini, A., The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J. Gastrointest. Liver Dis. JGLD 23 (2014), 387–391.
103. Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M.G., Reichmann, H., Funk, R.H.W., Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE, 2010, 5, 10.1371/journal.pone.0008762.
104. Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. a., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., Gille, G., Funk, R.H.W., Reichmann, H., Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci. Rep., 2, 2012, 898, 10.1038/srep00898.
105. Patel, R.M., Myers, L.S., Kurundkar, A.R., Maheshwari, A., Nusrat, A., Lin, P.W., Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 180 (2012), 626–635, 10.1016/j.ajpath.2011.10.025.
106. Perez-Pardo, P., de Jong, E.M., Broersen, L.M., van Wijk, N., Attali, A., Garssen, J., Kraneveld, A.D., Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease. Front. Aging Neurosci., 9, 2017, 57, 10.3389/fnagi.2017.00057.
107. Perez-Pardo, P., Dodiya, H.B., Broersen, L.M., Douna, H., van Wijk, N., Lopes da Silva, S., Garssen, J., Keshavarzian, A., Kraneveld, A.D., Gut–brain and brain–gut axis in Parkinson's disease models: effects of a uridine and fish oil diet. Nutr. Neurosci., 2017, 1–12, 10.1080/1028415X.2017.1294555.
108. Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease. Park. Relat. Disord. 17 (2011), 10–15, 10.1016/j.parkreldis.2010.08.003.
109. Poewe, W., Antonini, A., Zijlmans, J.C., Burkhard, P.R., Vingerhoets, F., Levodopa in the treatment of Parkinson's disease: an old drug still going strong. Clin. Interv. Aging 5 (2010), 229–238.
110. Ponsen, M.M., Stoffers, D., Twisk, J.W.R., Wolters, E.C., Berendse, H.W., Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Mov. Disord. Off. J. Mov. Disord. Soc. 24 (2009), 1060–1065, 10.1002/mds.22534.
111. Quigley, E.M.M., Quera, R., Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130 (2006), S78–S90, 10.1053/j.gastro.2005.11.046.
112. Rajkumar, H., Kumar, M., Das, N., Kumar, S.N., Challa, H.R., Nagpal, R., Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J. Cardiovasc. Pharmacol. Ther. 20 (2015), 289–298, 10.1177/1074248414555004.
113. Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M., Logan, A.C., A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog., 1, 2009, 6, 10.1186/1757-4749-1-6.
114. Rasmussen, H., Piazza, B., Forsyth, C., Keshavarzian, A., Nutrition and gastrointestinal health as modulators of Parkinson's disease. Folkerts, G., Garssen, J., (eds.) Pharma-Nutrition, AAPS Advances in the Pharmaceutical Sciences Series, 2014, Springer International Publishing, 213–242.
115. Reid, G., Younes, J.A., Van der Mei, H.C., Gloor, G.B., Knight, R., Busscher, H.J., Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 9 (2011), 27–38, 10.1038/nrmicro2473.
116. Remy, P., Doder, M., Lees, A., Turjanski, N., Brooks, D., Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain J. Neurol. 128 (2005), 1314–1322, 10.1093/brain/awh445.
117. Rhee, S.H., Pothoulakis, C., Mayer, E.A., Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6 (2009), 306–314, 10.1038/nrgastro.2009.35.
118. Robertson, D.R., Renwick, A.G., Macklin, B., Jones, S., Waller, D.G., George, C.F., Fleming, J.S., The influence of levodopa on gastric emptying in healthy elderly volunteers. Eur. J. Clin. Pharmacol. 42 (1992), 409–412.
119. Robertson, D.R., Renwick, A.G., Wood, N.D., Cross, N., Macklin, B.S., Fleming, J.S., Waller, D.G., George, C.F., The influence of levodopa on gastric emptying in man. Br. J. Clin. Pharmacol. 29 (1990), 47–53.
120. Ross, G.W., Abbott, R.D., Petrovitch, H., Tanner, C.M., Davis, D.G., Nelson, J., Markesbery, W.R., Hardman, J., Masaki, K., Launer, L., White, L.R., Association of olfactory dysfunction with incidental Lewy bodies. Mov. Disord. Off. J. Mov. Disord. Soc. 21 (2006), 2062–2067, 10.1002/mds.21076.
121. Sakakibara, R., Odaka, T., Uchiyama, T., Asahina, M., Yamaguchi, K., Yamaguchi, T., Yamanishi, T., Hattori, T., Colonic transit time and rectoanal videomanometry in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 74 (2003), 268–272.
122. Sakamoto, T., Cansev, M., Wurtman, R.J., Oral supplementation with docosahexaenoic acid and uridine-5’-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 1182 (2007), 50–59, 10.1016/j.brainres.2007.08.089.
123. Sánchez-Ferro, Á., Rábano, A., Catalán, M.J., Rodríguez-Valcárcel, F.C., Fernández Díez, S., Herreros-Rodríguez, J., García-Cobos, E., Álvarez-Santullano, M.M., López-Manzanares, L., Mosqueira, A.J., Vela Desojo, L., López-Lozano, J.J., López-Valdés, E., Sánchez-Sánchez, R., Molina-Arjona, J.A., In vivo gastric detection of α-synuclein inclusions in Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 30 (2015), 517–524, 10.1002/mds.25988.
124. Sartor, R.B., Probiotic therapy of intestinal inflammation and infections. Curr. Opin. Gastroenterol. 21 (2005), 44–50.
125. Savica, R., Carlin, J.M., Grossardt, B.R., Bower, J.H., Ahlskog, J.E., Maraganore, D.M., Bharucha, A.E., Rocca, W.A., Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 73 (2009), 1752–1758, 10.1212/WNL.0b013e3181c34af5.
126. Savignac, H.M., Corona, G., Mills, H., Chen, L., Spencer, J.P.E., Tzortzis, G., Burnet, P.W.J., Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem. Int. 63 (2013), 756–764, 10.1016/j.neuint.2013.10.006.
127. Scheperjans, F., Aho, V., Pereira, P.A.B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola-Rautio, J., Pohja, M., Kinnunen, E., Murros, K., Auvinen, P., Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. Off. J. Mov. Disord. Soc. 30 (2015), 350–358, 10.1002/mds.26069.
128. Scholtens, P.A.M.J., Goossens, D.A.M., Staiano, A., Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review. World J. Gastroenterol. 20 (2014), 13446–13452, 10.3748/wjg.v20.i37.13446.
129. Schrag, A., Quinn, N., Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain J. Neurol. 123:Pt 11 (2000), 2297–2305.
130. Schrezenmeir, J., de Vrese, M., Probiotics, prebiotics, and synbiotics–approaching a definition. Am. J. Clin. Nutr. 73 (2001), 361S–364S.
131. Shannon, K.M., Keshavarzian, A., Dodiya, H.B., Jakate, S., Kordower, J.H., Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases. Mov. Disord. 27 (2012), 716–719, 10.1002/mds.25020.
132. Shannon, K.M., Keshavarzian, A., Mutlu, E., Dodiya, H.B., Daian, D., Jaglin, J.A., Kordower, J.H., Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 27 (2012), 709–715, 10.1002/mds.23838.
133. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P.D., Manicassamy, S., Munn, D.H., Lee, J.R., Offermanns, S., Ganapathy, V., Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139, 10.1016/j.immuni.2013.12.007.
134. Svensson, E., Horváth-Puhó, E., Thomsen, R.W., Djurhuus, J.C., Pedersen, L., Borghammer, P., Sørensen, H.T., Vagotomy and subsequent risk of Parkinson's disease. Ann. Neurol., 2015, 10.1002/ana.24448.
135. Tan, A.H., Mahadeva, S., Thalha, A.M., Gibson, P.R., Kiew, C.K., Yeat, C.M., Ng, S.W., Ang, S.P., Chow, S.K., Tan, C.T., Yong, H.S., Marras, C., Fox, S.H., Lim, S.-Y., Small intestinal bacterial overgrowth in Parkinson's disease. Park. Relat. Disord. 20 (2014), 535–540, 10.1016/j.parkreldis.2014.02.019.
136. Unger, M.M., Möller, J.C., Mankel, K., Eggert, K.M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P.H., Mayer, G., Tebbe, J.J., Oertel, W.H., Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?. J. Neurol. 258 (2011), 982–990, 10.1007/s00415-010-5864-1.
137. Unger, M.M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., Schäfer, K.-H., Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Park. Relat. Disord., 2016, 10.1016/j.parkreldis.2016.08.019.
138. van Hoffen, E., Ruiter, B., Faber, J., M'Rabet, L., Knol, E.F., Stahl, B., Arslanoglu, S., Moro, G., Boehm, G., Garssen, J., A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64 (2009), 484–487, 10.1111/j.1398-9995.2008.01765.x.
139. Van Wijk, N., Broersen, L.M., De Wilde, M.C., Hageman, R.J.J., Groenendijk, M., Sijben, J.W.C., Kamphuis, P.J.G.H., Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J. Alzheimers Dis. 38 (2014), 459–479, 10.3233/JAD-130998.
140. van Wijk, N., Broersen, L.M., de Wilde, M.C., Hageman, R.J.J., Groenendijk, M., Sijben, J.W.C., Kamphuis, P.J.G.H., Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J. Alzheimers Dis. 38 (2014), 459–479, 10.3233/JAD-130998.
141. Varankovich, N.V., Nickerson, M.T., Korber, D.R., Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front. Microbiol., 6, 2015, 685, 10.3389/fmicb.2015.00685.
142. Verbaan, D., Marinus, J., Visser, M., van Rooden, S.M., Stiggelbout, A.M., van Hilten, J.J., Patient-reported autonomic symptoms in Parkinson disease. Neurology 69 (2007), 333–341, 10.1212/01.wnl.0000266593.50534.e8.
143. Visanji, N.P., Brooks, P.L., Hazrati, L.-N., Lang, A.E., The prion hypothesis in Parkinson's disease: braak to the future. Acta Neuropathol. Commun., 1, 2013, 2, 10.1186/2051-5960-1-2.
144. Waller, D.G., Roseveare, C., Renwick, A.G., Macklin, B., George, C.F., Gastric emptying in healthy volunteers after multiple doses of levodopa. Br. J. Clin. Pharmacol. 32 (1991), 691–695.
145. Waseem, S., Gwinn-Hardy, K., Pain in Parkinson's disease. common yet seldom recognized symptom is treatable. Postgrad. Med. 110 (2001), 33–34 (39–40, 46).
146. Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., Mandel, J., Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur. J. Epidemiol. 26:Suppl 1 (2011), S1–S58, 10.1007/s10654-011-9581-6.
147. Wurtman, R.J., A nutrient combination that can affect synapse formation. Nutrients 6 (2014), 1701–1710, 10.3390/nu6041701.
148. Wurtman, R.J., Cansev, M., Sakamoto, T., Ulus, I.H., Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 29 (2009), 59–87, 10.1146/annurev-nutr-080508-141059.
149. Wurtman, R.J., Ulus, I.H., Cansev, M., Watkins, C.J., Wang, L., Marzloff, G., Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 1088 (2006), 83–92, 10.1016/j.brainres.2006.03.019.
150. Zaharoni, H., Rimon, E., Vardi, H., Friger, M., Bolotin, A., Shahar, D.R., Probiotics improve bowel movements in hospitalized elderly patients–the PROAGE study. J. Nutr. Health Aging 15 (2011), 215–220.
151. Zareie, M., Johnson-Henry, K., Jury, J., Yang, P.-C., Ngan, B.-Y., McKay, D.M., Soderholm, J.D., Perdue, M.H., Sherman, P.M., Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55 (2006), 1553–1560, 10.1136/gut.2005.080739.
152. Zerbi, V., Jansen, D., Wiesmann, M., Fang, X., Broersen, L.M., Veltien, A., Heerschap, A., Kiliaan, A.J., Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. Neurobiol. Aging 35 (2014), 600–613, 10.1016/j.neurobiolaging.2013.09.038.